Salta al contenuto principale
Passa alla visualizzazione normale.

Ricerca avanzata per:

Risultati della ricerca

  • 1. SEMINAR-NOVEMBER-17-2014 (100%)

    28-ott-2014 17.08.16

    ) Human ex vivo and in vitro models of asthma for the study of allergic airway inflammation. Abstract. Asthma is an inflammatory disorder of the conducting airways which undergo distinct structural ... environmental influences whose multifactorial interactions can result in a range of asthma phenotypes. Since ... a major challenge to the logical development of in vivo ‘models of asthma’ using animals. However, use ... volunteers. Asthma research has been greatly facilitated by the introduction of fiberoptic

  • 2. International summit on severe asthma and concomitant diseases, organizzato dal prof. Nicola Scichilone (92%)

    10-feb-2023 12.09.58

    International summit on severe asthma and concomitant diseases, organizzato dal prof. Nicola Scichilone articolo, notizia, unipa, International summit on severe asthma and concomitant diseases, Nicola Scichilone, promise, terza_missione, ECM, specializzazioni, Simreg, Società italiana di medicina respiratoria in età geriatrica International summit on severe asthma and concomitant diseases Policlinico, Tecniche innovative nel centro di riferimento regionale per l’asma grave. L’ex astronauta

  • 3. C.V. prof. Scichilone (66%)

    17-nov-2020 13.28.11

    la Johns Hopkins University, Asthma and Allergy Center, Baltimore,  Maryland, USA. 1999-2004 ... and reversibility in adult patients with asthma. Chest 1998; 114:1336-1342.   1. Cuttitta G, Cibella F ... inspiration and its absence in asthma. J Appl Physiol 2000; 89:711-720.  1. Scichilone N, Kapsali ... , Scichilone N, Catalano F, Cuttitta G.  Prevalence of nocturnal asthma in a general population sample: determinants and effect of aging. J Asthma. 2000; 37(7):595-602.   1. Scichilone N, Permutt S

  • 4. Seminario del Dottorato di ricerca in BIOMEDICINA E NEUROSCIENZE (52%)

    19-nov-2014 9.47.02

    Seminario del Dottorato di ricerca in BIOMEDICINA E NEUROSCIENZE asthma, ex vivo models, in vitro models, Dottorato, Biomedicina, Neuroscienze Lunedì 17 Novembre 2014 alle ore 14:30 nell’aula Nesci della Sezione di Anatomia del Dipartimento BioNeC (Policlinico Universitario), la prof.ssa Donna E. Davies (Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton) terrà un seminario dal titolo “Human ex vivo and in vitro models of asthma for the study of allergic airway

  • 6. Patrocinio - Evento scientifico "2nd International Course on Severe Asthma and associated comobidities" - Palermo, 10-11 maggio 2019 (33%)

    4-gen-2019 10.05.55

    0 94124 0,00 Patrocinio - Evento scientifico "2nd International Course on Severe Asthma and associated comobidities" - Palermo, 10-11 maggio 2019 patrocinio, coordinamento, cerimoniale ROSANNA CUFFARI /sites/portale/_categories/decreto/

  • 7. Gratuito Patrocinio - Congresso scientifico " SEVERE ASTHMA" - Palermo, 26/27 aprile 2017 (33%)

    5-apr-2017 12.22.52

    0 1469 0,00 Gratuito Patrocinio - Congresso scientifico " SEVERE ASTHMA" - Palermo, 26/27 aprile 2017 provvedimenti, rettorato, trasparenza VITA IGNIZIO /sites/portale/_categories/decreto/

  • 8. AREA 06 - SCIENZE E BIOTECNOLOGIE - Feo (33%)

    8-mar-2013 23.05.34

    , Canonica GW. RhinAsthma patient perspective: a short daily asthma and rhinitis QoL assessment ... . Bronchodilation response to deep inspirations in asthma is dependent on airway distensibility and ... of intranasal corticosteroids on asthma control and quality of life in allergic rhinitis with mild asthma. J Asthma 2011;48(1):41-7. Sorino C, Battaglia S, Scichilone N, Pedone C, Antonelli-Incalzi R ... small airways in asthma. Allergy. 2010 Jul;65(7):897-902 Mercadante S, Craig D, Giarratano A. US Food

  • 9. Concessione Patrocinio dell’Ateneo e utilizzo del Logo " INTERNATIONAL SUMMIT ON SEVERE ASTHMA and concomitant Diseases” – 3 e 4 febbraio 2023 – NH Hotel Palermo - (32%)

    10-nov-2023 17.20.41

    0 7993 0,00 Concessione Patrocinio dell’Ateneo e utilizzo del Logo " INTERNATIONAL SUMMIT ON SEVERE ASTHMA and concomitant Diseases” – 3 e 4 febbraio 2023 – NH Hotel Palermo - concessione, patrocinio, cerimoniale, rettorato ROSANNA CUFFARI /sites/portale/_categories/decreto/

  • 10. concorso pubblico, per titoli ed esame-colloquio, per l’attribuzione di n° 1 borsa di studio post-lauream della durata di mesi 12 e per l’importo di € 21.600,00 per attività di ricerca dal titolo “La gestione della ricerca clinica negli ambulatori di pneumologia per le patologie croniche respiratorie ad elevata complessità.” da far gravare su fondi GSK - Call 2018, Innovation in severe refractory asthma - Codice: R4D04-ASS-RIC-GLAXO-SCICHI-2018, Responsabile Scientifico: Prof. Nicola Scichilone ; Codice Concorso: BS-RIC 123-2019,, indetto con D.R. n° 3467 del 18/10/2019 – NOMINA COMMISSIONE (29%)

    14-gen-2020 12.32.33

    0000 109356 0000,00 concorso pubblico, per titoli ed esame-colloquio, per l’attribuzione di n° 1 borsa di studio post-lauream della durata di mesi 12 e per l’importo di € 21.600,00 per attività di ricerca dal titolo “La gestione della ricerca clinica negli ambulatori di pneumologia per le patologie croniche respiratorie ad elevata complessità.” da far gravare su fondi GSK - Call 2018, Innovation in severe refractory asthma - Codice: R4D04-ASS-RIC-GLAXO-SCICHI-2018, Responsabile

  • 11. Moukri graphical_abstract (28%)

    22-mag-2021 18.18.26

    will focus on eosinophilic asthma. Asthma is a I. Fabrication of heterogeneous disease that causes ... on eosinophilic asthma, we will find the most electroactive tag. suitable protein as asthma biomarker and ... for the detection of biomarkers of inflammatory diseases with a focus on eosinophilic asthma. In order

  • 12. Pubblicazioni 2021_2023 (27%)

    13-feb-2024 10.25.30

  • 13. Programma_congresso_Palermo_COVID_malattie_respiratorie (27%)

    28-apr-2022 11.17.40

    . Scichilone Chairs: A. Carroccio, F. Di Gesù, G. Valenti 09.00 - 09.20 Global Initiative for Asthma (GINA ... in asthma and allergic diseases - A. Togias 15.20 - 15.40 Il ruolo della medicina generale nel post COVID ... . Di Gesù, G. Valenti 09.00 - 09.20 Global Initiative for Asthma (GINA) strategy 2021 - key changes ... . Aliberti 18.30 - 19.00 SARS-CoV-2 infection and vaccination in asthma and allergic diseases ... Initiative for Asthma (GINA) strategy 2021 - key changes - A. A. Cruz 14.40 - 15.30 Saluti delle

  • 14. 15 english version bando 2021 (24%)

    18-feb-2021 10.52.11

    of clinical research in severe asthma: the role of the research coordinator”, to be carried out ... in severe asthma: the role of the research coordinator - Description: Severe asthma represents ... on the identification of asthma phenotypes, considered as the evaluation of clinical, functional and ... of patients affected by severe asthma. Therefore, the research Coordinator will be involved

  • 15. Trial conclusi (24%)

    27-gen-2026 16.34.32

    of GSK3511294 (Depemokimab) in adult and adolescent participants with severe asthma ... number 2020-004334-38 Conditions Severe asthma with an eosinophilic phenotype Asma grave ... for Severe Asthma Patients. A New, Non-invasive Approach for the Monitoring of Inflammation in Severe Asthma Patients on Biologics NCT Number NCT05946421 Conditions Intervention/treatment Severe Asthma Interventions Device: exhaled breath analysis Sponsor Gender All Age 18 Years and older (Adult

  • 16. Studi Osservazionali 2023 (22%)

    10-ott-2023 16.15.45

    for Severe Asthma Patients. A New, Non-invasive Approach for the Monitoring of Inflammation in Severe Asthma Patients on Biologics NCT Number NCT05946421 Conditions Intervention/treatment Severe Asthma

  • 17. Studi Osservazionali conclusi (22%)

    24-gen-2026 18.12.19

    Study: Breath Analysis for Severe Asthma Patients. A New, Non-invasive Approach for the Monitoring of Inflammation in Severe Asthma Patients on Biologics NCT Number NCT05946421 Conditions Intervention/treatment Severe Asthma Interventions Device: exhaled breath analysis Gender All Age 18 Years and older

  • 18. 15 bando 2021 (22%)

    18-feb-2021 10.52.11

    : “Implementation of clinical research in severe asthma: the role of the research coordinator ... stessi. - Description: Severe asthma represents a substantial burden for affected patients ... . In the last few years, much interest has been addressed on the identification of asthma phenotypes ... of our Centre is to improve the assessment and management of patients affected by severe asthma

  • 19. bando_bs_15-2024_scichilone (22%)

    2-feb-2024 10.25.08

    Preclinico dal titolo “Ex vivo 3D model of T2-asthma and the effects of dupilumab”, sottoscritto dalla ... Sanofi Srl – PROMISE, studio “Ex vivo 3D model of T2-asthma and the effects of dupilumab”, Codice ... su: Contratto Sanofi Srl – PROMISE, studio “Ex vivo 3D model of T2-asthma and the effects of dupilumab ... studio “Ex vivo 3D model of T2-asthma and the effects of dupilumab”, Codice Progetto

  • 20. TRIAL 2020 (19%)

    13-dic-2022 14.49.14

    TRIAL 2020 articolo, notizia, unipa Elenco Trial - Anno 2020 Elenco Schede TRIAL - Anno 2020 Title Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients NCT Number NCT04181190 Conditions Asthma|Asthma; Eosinophilic Interventions Diagnostic Test: Total IgE|Diagnostic Test: Blood cell counts|Diagnostic Test: Asthma control assessment|Diagnostic Test: lung function tests Sponsor/Collaborators Università degli Studi di Ferrara Gender All Age Child, Adult, Older